Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

2000624 citationsJournal Articlebronze Open Access

Authors

Abstract

Galantamine is effective and well tolerated in Alzheimer's disease. As galantamine slowed the decline of functional ability as well as cognition, its effects are likely to be clinically relevant.

Topics & Keywords

Alzheimer's disease research and treatments Dementia and Cognitive Impairment Research Cholinesterase and Neurodegenerative Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ

Volume 321, Issue 7274, pp. 1445-1445

DOI: 10.1136/bmj.321.7274.1445

Field-Weighted Citation Impact: 22.01